Viral Vectors and Plasmid DNA Manufacturing Market Projected to Surpass $34 Billion by 2033 The global market for viral vectors and plasmid DNA manufacturing is set to reach $34 billion by 2033, driven by growth in gene therapy and rising disease prevalence.

Viral Vectors and Plasmid DNA Manufacturing Market Projected to Surpass $34 Billion by 2033 #USA #gene_therapy #Portland #Plasmid_DNA #viral_vectors